Department of Oral and Maxillofacial Surgery, Faculty of Dentistry (Khorasgan), Isfahan Azad University, Isfahan, Iran.
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Tehran medical sciences, Islamic Azad University, Tehran, Iran.
Clin Exp Dent Res. 2024 Jun;10(3):e875. doi: 10.1002/cre2.875.
The bone regeneration therapy is often used in patients with inadequate bone support for implants, particularly following tooth extractions. Xenografts derived from animal tissues are effective bone reconstructive options that resist resorption and pose a low risk of transmitting disease. Therefore, these implants may be a good option for enhancing and stabilizing maxillary sinuses. The purpose of this study was to compare two xenografts, BoneB® and InterOss®, for the reconstruction of rabbit calvaria defects.
The study involved seven male New Zealand white rabbits. In the surgical procedure, 21 spots were created on both sides of the midline calvarium by creating three 8-millimeter defects. A control group was used, as well as two treatment groups utilizing BoneB® Grafts and InterOss® Grafts. After 3 months, the rabbits were euthanized, followed by pathological evaluation. Analysis of these samples focused on bone formation, xenograft remaining material, and inflammation levels, using Adobe Photoshop CS 8.0 and SPSS version 24.
With the application of BoneB® graft, bone formation ranged from 32% to 45%, with a mean of 37.80% (±5.63), and the remaining material ranged from 28% to 37%, with a mean of 32.60% (±3.65). Using InterOss® grafts, bone formation was 61% to 75%, the mean was 65.83% (±4.75), and the remaining material was 9% to 18%, with a mean of 13.17% (±3.06). The bone formation in the control group ranged from 10% to 25%, with a mean of 17.17% (±6.11). InterOss® had lower inflammation levels than other groups, but the difference was not statistically significant (p > .05).
InterOss® bone powder is the best option for maxillofacial surgery and bone reconstruction. This is due to more bone formation, less remaining material, and a lower inflammation level. Compared to the control group, BoneB® improves healing and bone quality, thus making it an alternative to InterOss®.
骨再生疗法常用于因植入物骨支持不足的患者,特别是拔牙后。源自动物组织的异种移植物是有效的骨重建选择,可抵抗吸收并降低传播疾病的风险。因此,这些植入物可能是增强和稳定上颌窦的良好选择。本研究旨在比较两种异种移植物,BoneB®和 InterOss®,用于兔颅骨缺损的重建。
本研究涉及 7 只雄性新西兰白兔。在手术过程中,通过创建 3 个 8 毫米的缺损,在中线颅骨的两侧创建了 21 个部位。使用对照组以及使用 BoneB®移植物和 InterOss®移植物的两组治疗组。3 个月后,处死兔子,然后进行病理评估。使用 Adobe Photoshop CS 8.0 和 SPSS 版本 24 分析这些样本,重点关注骨形成、异种移植物剩余材料和炎症水平。
应用 BoneB®移植物时,骨形成率为 32%至 45%,平均为 37.80%(±5.63),剩余材料率为 28%至 37%,平均为 32.60%(±3.65)。使用 InterOss®移植物时,骨形成率为 61%至 75%,平均为 65.83%(±4.75),剩余材料率为 9%至 18%,平均为 13.17%(±3.06)。对照组的骨形成率为 10%至 25%,平均为 17.17%(±6.11)。与其他组相比,InterOss®的炎症水平较低,但差异无统计学意义(p>.05)。
InterOss®骨粉是颌面外科和骨重建的最佳选择。这是因为它具有更多的骨形成、更少的剩余材料和更低的炎症水平。与对照组相比,BoneB®可改善愈合和骨质量,因此是 InterOss®的替代品。